ILMN Illumina, Inc.
Healthcare$145.27+0.00%OpenMarket Cap: $21.98B
As of 2026-05-26
Valuation
P/E (TTM)
21.75
PEG
0.13
P/B
8.26
P/S
4.98
EV/EBITDA
19.15
DCF Value
$-62.74
FCF Yield
4.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.7%
Operating Margin
21.5%
Net Margin
19.4%
ROE
34.0%
ROA
13.0%
ROIC
13.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.09B | 68.2% | $232.0M | $134.0M | $— | — |
| Q4 null | $1.16B | 67.1% | $257.0M | $334.0M | $— | — |
| FY null | $4.34B | 66.7% | $864.0M | $850.0M | $— | — |
| Q3 null | $1.08B | 67.6% | $231.0M | $150.0M | $— | — |
| Q2 null | $1.06B | 67.8% | $222.0M | $235.0M | $— | — |
| Q1 null | $1.04B | 65.8% | $184.0M | $131.0M | $— | — |
| Q4 null | $1.10B | 65.9% | $202.0M | $187.0M | $— | — |
| FY null | $4.37B | 65.4% | $-833.0M | $-1.22B | $— | — |
| Q3 null | $1.08B | 69.0% | $741.0M | $705.0M | $— | — |
| Q2 null | $1.11B | 64.8% | $-1.64B | $-1.99B | $— | — |
| Q1 null | $1.08B | 62.0% | $-111.0M | $-126.0M | $— | — |
| Q4 2023 | $1.12B | 60.1% | $-164.0M | $-175.0M | $-1.11 | — |